JNJ · Johnson & Johnson GP
last $270.08-0.26%volume $15.61Mmarket cap n/afeed alpacaas of 2026-09-25 15:32
one year · daily closes52-week high $278.4552-week low $176.701m -0.9%3m +10.6%1y +53.2%
FA · financials · Johnson & Johnson from the company's own filingsEDGAR ↗
| quarter ending | 2026-06-28 | 2026-03-29 | 2025-12-28 | 2025-09-28 | 2025-06-29 | 2025-03-30 | 2024-12-29 | 2024-09-29 |
|---|---|---|---|---|---|---|---|---|
| revenue | $25.31B | $24.06B | $24.56B | $23.99B | $23.74B | $21.89B | $22.52B | $22.47B |
| net income | $5.53B | $5.24B | $5.12B | $5.15B | $5.54B | $11.00B | $3.43B | $2.69B |
| EPS (diluted) | 2.27 | 2.14 | 2.09 | 2.12 | 2.29 | 4.54 | 1.41 | 1.11 |
| operating cash flow | $8.62B | $2.51B | $7.31B | $9.17B | $3.88B | $4.17B | $6.98B | $7.99B |
total assets $201.06B (2026-06-28)cash $20.42B (2026-06-28)long term debt $37.34B (2026-06-28)equity $84.97B (2026-06-28)shares outstanding 2,409,898,597 (2026-07-17)
quarterly figures as filed (10-Q / 10-K); where a company reports year-to-date, the quarter is the difference. No estimates.
news · JNJmore →
no matching headlines in the last hours